Metabolic clearance of vasopressin and an analogue resistant to vasopressinase in human pregnancy.
The metabolic clearance rate (MCR) of arginine vasopressin (AVP) increases fourfold during human pregnancy. To explore whether circulating vasopressinase may play a role in this change, six women underwent a three-tier infusion clearance study, twice, in random order, to determine the MCRs of either AVP or 1-deamino-8-D-AVP (dDAVP, an analogue resistant to degradation by vasopressinase). Volunteers were tested in late pregnancy (LP), 24-48 h postdelivery (PD), and 5-6 (PP1) and 10-12 (PP2) wk postpartum, thus examining MCRs when vasopressinase levels were high, before and after removal of the placenta (LP and PD), and when plasma enzyme activity was becoming (PP1) and became (PP2) undetectable. Manipulation of infusate permitted comparison of MCRs at three plasma levels whose range was similar at each test period. PAVP and PdDAVP (2.2 and 10 pg/ml, respectively, during the initial infusion) increased to 8 and 31 pg/ml, stepwise increments that had no influence on respective MCRs (AVP: 3.4, 2.2, 0.77, and 0.67 l/min during LP, PD, PP1, and PP2 compared with 0.18, 0.21, 0.17, and 0.15 l/min for dDAVP). Comparison of similar and submaximal urinary osmolality revealed PdDAVP values three- to fourfold greater than PAVP. Von Willebrand factor (VWF) and factor VIIIc levels increased almost fourfold in response to dDAVP during pregnancy, but only doubled in the nonpregnant state; these differences did not reach significance. We conclude that although AVP disposal rates increase fourfold in pregnancy, those of dDAVP change little, suggesting a role of vasopressinase in the increased MCR of AVP in gestation (as well as in the genesis of certain polyuric disorders of pregnancy).(ABSTRACT TRUNCATED AT 250 WORDS)
Davison
J M
JM
Department of Obstetrics and Gynaecology, Princess Mary Maternity Hospital, University of Newcastle, United Kingdom.
Sheills
E A
EA
Philips
P R
PR
Barron
W M
WM
Lindheimer
M D
MD
D001127:Arginine Vasopressin / Q000097:blood*; D010122:Cystinyl Aminopeptidase / Q000097:blood*; D003894:Deamino Arginine Vasopressin / Q000097:blood*; D005169:Factor VIII / Q000032:analysis; D005260:Female; D006801:Humans; D008657:Metabolic Clearance Rate; D049590:Postpartum Period; D011247:Pregnancy / Q000097:blood*; D011263:Pregnancy Trimester, Third; D014841:von Willebrand Factor / Q000032:analysis
D014841:von Willebrand Factor; D001127:Arginine Vasopressin; D005169:Factor VIII; D010122:Cystinyl Aminopeptidase; D003894:Deamino Arginine Vasopressin